Initial observations of homozygous mutants showed a phenotype with neuromuscular deficits, such as muscle atrophy, ataxia, sensory deficits, and decreased muscular endurance, indicating that these mice could potentially be a useful mouse model of CMT2A. The gene discussed is KIF1B; the disease is cerebellar ataxia.